Funding
← Back to your selection

Sanofi Ventures

Activity from announced rounds

Activity in this selectionEurope
Rounds participated in
3
Confirmed lead rounds
0
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$540M
3 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1
Series C+1

By primary sector

Biotech3

By country

United Kingdom2
France1

Rounds

3 in this selection
OMass Therapeutics

OMass Therapeutics develops small-molecule medicines for endocrine and immune diseases using a platform that measures drug targets in their biological surroundings.

$310MSeries C
Participant
Bionyra Pharma

Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases.

$165MSeries A
Role not disclosed